198 related articles for article (PubMed ID: 30228352)
1. Hemodialysis-related changes in phenotypical features of monocytes.
Liakopoulos V; Jeron A; Shah A; Bruder D; Mertens PR; Gorny X
Sci Rep; 2018 Sep; 8(1):13964. PubMed ID: 30228352
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease.
Borges Bonan N; Schepers E; Pecoits-Filho R; Dhondt A; Pletinck A; De Somer F; Vanholder R; Van Biesen W; Moreno-Amaral A; Glorieux G
Sci Rep; 2019 Jul; 9(1):10236. PubMed ID: 31308443
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic markers on lymphocytes and monocytes are unchanged during single hemodialysis sessions using either regenerated cellulose or polysulfone membranes.
Wu CC; Liao TN; Lu KC; Chen JS; Chu P; Lin SH; Chuang CH; Lin YF
Clin Nephrol; 2005 Sep; 64(3):198-204. PubMed ID: 16175944
[TBL] [Abstract][Full Text] [Related]
4. Expression of Fc gamma receptor III (CD16) on monocytes during hemodialysis in patients with chronic renal failure.
Kawanaka N; Nagake Y; Yamamura M; Makino H
Nephron; 2002 Jan; 90(1):64-71. PubMed ID: 11744807
[TBL] [Abstract][Full Text] [Related]
5. Haemodialysis monocytopenia: differential sequestration kinetics of CD14+CD16+ and CD14++ blood monocyte subsets.
Nockher WA; Wiemer J; Scherberich JE
Clin Exp Immunol; 2001 Jan; 123(1):49-55. PubMed ID: 11167997
[TBL] [Abstract][Full Text] [Related]
6. Biocompatibility study based on differential sequestration kinetics of CD14+CD16+ blood monocyte subsets with different dialyzers.
Griveas I; Visvardis G; Sakellariou G; Passadakis P; Thodis I; Vargemezis V; Pavlitou A; Fleva A
Ren Fail; 2006; 28(6):493-9. PubMed ID: 16928619
[TBL] [Abstract][Full Text] [Related]
7. Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment.
Sester U; Sester M; Heine G; Kaul H; Girndt M; Köhler H
Nephrol Dial Transplant; 2001 Jul; 16(7):1402-8. PubMed ID: 11427632
[TBL] [Abstract][Full Text] [Related]
8. Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS.
Nockher WA; Scherberich JE
Kidney Int; 1995 Nov; 48(5):1469-76. PubMed ID: 8544403
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets.
Tallone T; Turconi G; Soldati G; Pedrazzini G; Moccetti T; Vassalli G
J Cardiovasc Transl Res; 2011 Apr; 4(2):211-9. PubMed ID: 21308491
[TBL] [Abstract][Full Text] [Related]
10. Microinflammation in hemodialysis is related to a preactivated subset of monocytes.
Ramirez R; Carracedo J; Berdud I; Carretero D; Merino A; Rodríguez M; Tetta C; Martín-Malo A; Aljama P
Hemodial Int; 2006 Jan; 10 Suppl 1():S24-7. PubMed ID: 16441864
[TBL] [Abstract][Full Text] [Related]
11. Losartan prevents the development of the pro-inflammatory monocytes CD14+CD16+ in haemodialysis patients.
Merino A; Alvarez-Lara MA; Ramirez R; Carracedo J; Martin-Malo A; Aljama P
Nephrol Dial Transplant; 2012 Jul; 27(7):2907-12. PubMed ID: 22247233
[TBL] [Abstract][Full Text] [Related]
12. Uremic Toxicity-Induced Eryptosis and Monocyte Modulation: The Erythrophagocytosis as a Novel Pathway to Renal Anemia.
Bonan NB; Steiner TM; Kuntsevich V; Virzì GM; Azevedo M; Nakao LS; Barreto FC; Ronco C; Thijssen S; Kotanko P; Pecoits-Filho R; Moreno-Amaral AN
Blood Purif; 2016; 41(4):317-23. PubMed ID: 26848873
[TBL] [Abstract][Full Text] [Related]
13. Expansion of CD4+CD16+ blood monocytes in patients with chronic renal failure undergoing dialysis: possible involvement of macrophage colony-stimulating factor.
Saionji K; Ohsaka A
Acta Haematol; 2001; 105(1):21-6. PubMed ID: 11340249
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists.
Lacerte P; Brunet A; Egarnes B; Duchêne B; Brown JP; Gosselin J
Arthritis Res Ther; 2016 Jan; 18():10. PubMed ID: 26759164
[TBL] [Abstract][Full Text] [Related]
15. [Expression of Fas on monocytes and the level of plasma soluble FasL in patients with chronic renal failure].
Jiang J; Hou F; Liu Z; Liu J; Zhang X
Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):25-8. PubMed ID: 11798554
[TBL] [Abstract][Full Text] [Related]
16. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional analysis of monocyte populations in cattle peripheral blood identifies a subset with high endocytic and allogeneic T-cell stimulatory capacity.
Corripio-Miyar Y; Hope J; McInnes CJ; Wattegedera SR; Jensen K; Pang Y; Entrican G; Glass EJ
Vet Res; 2015 Sep; 46():112. PubMed ID: 26407849
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD206 and CD163 on intermediate CD14
Li X; Du N; Xu G; Zhang P; Dang R; Jiang Y; Zhang K
Virus Res; 2018 Jul; 253():92-102. PubMed ID: 29857122
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients.
de Cal M; Cruz DN; Corradi V; Nalesso F; Polanco N; Lentini P; Brendolan A; Tetta C; Ronco C
Blood Purif; 2008; 26(3):249-54. PubMed ID: 18376106
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure.
Pereira R; Costa E; Gonçalves M; Miranda V; do Sameiro Faria M; Quintanilha A; Belo L; Lima M; Santos-Silva A
Hemodial Int; 2010 Jul; 14(3):295-301. PubMed ID: 20649681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
